Skip to main content
SpringerLink
Log in

Role of Inflammation in Depression and Treatment Implications

  • Chapter
  • First Online:
Antidepressants

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 250))

Abstract

Approximately one third of depressed patients fail to respond to currently available antidepressant therapies. Therefore, new conceptual frameworks are needed to identify pathophysiologic pathways and neurobiological targets for the development of novel treatment strategies. In this regard, recent evidence suggests that inflammation may contribute to symptoms relevant to a number of psychiatric disorders and particularly depression. Numerous studies (including meta-analyses) have found elevated peripheral and central inflammatory cytokines and acute phase proteins in depression. Chronic exposure to increased inflammation is thought to drive changes in neurotransmitters and neurocircuits that lead to depressive symptoms and that may also interfere with or circumvent the efficacy of antidepressants. Indeed, patients with high inflammation have been shown to exhibit poor response to conventional antidepressant therapies. Recent developments in our ability to understand and measure the effects of inflammation on the brain in patients have opened new doors for the testing of novel treatment strategies that target the immune system or its consequences on neurotransmitter systems. Such recent developments in the field of behavioral immunology and their translational implications for the treatment of depression are discussed herein.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • aan het Rot M, Collins KA, Murrough JW et al (2010) Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 67(2):139–145

    Article  CAS  Google Scholar 

  • Ahles TA, Saykin AJ, Furstenberg CT et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20(2):485–493

    Article  CAS  PubMed  Google Scholar 

  • Au B, Smith KJ, Gariepy G, Schmitz N (2015) The longitudinal associations between C-reactive protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing (ELSA). Int J Geriatr Psychiatry 30(9):976–984

    Article  PubMed  Google Scholar 

  • Aziz N, Fahey JL, Detels R, Butch AW (2003) Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol 10(4):652–657

    CAS  PubMed  PubMed Central  Google Scholar 

  • Banks WA, Erickson MA (2010) The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 37(1):26–32

    Article  CAS  PubMed  Google Scholar 

  • Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2(4):241–248

    Article  CAS  PubMed  Google Scholar 

  • Banks WA, Farr SA, Morley JE (2002) Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 10(6):319–327

    Article  CAS  PubMed  Google Scholar 

  • Beattie E, Stellwagen D, Morishita W et al (2002) Control of synaptic strength by glial TNFalpha. Science 295(5563):2282–2285

    Article  CAS  PubMed  Google Scholar 

  • Behan WM, McDonald M, Darlington LG, Stone TW (1999) Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol 128(8):1754–1760

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Berk M, Williams LJ, Jacka FN et al (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bjork JM, Grant SJ, Chen G, Hommer DW (2014) Dietary tyrosine/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing. Neuropsychopharmacology 39(3):595–604

    Article  CAS  PubMed  Google Scholar 

  • Bluthe RM, Walter V, Parnet P et al (1994) Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III 317(6):499–503

    CAS  PubMed  Google Scholar 

  • Bonaccorso S, Marino V, Puzella A et al (2002) Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22(1):86–90

    Article  CAS  PubMed  Google Scholar 

  • Bosker FJ, Hartman CA, Nolte IM et al (2011) Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16(5):516–532

    Article  CAS  PubMed  Google Scholar 

  • Bower JE, Irwin MR (2016) Mind-body therapies and control of inflammatory biology: a descriptive review. Brain Behav Immun 51:1–11

    Article  PubMed  Google Scholar 

  • Bower JE, Ganz PA, Aziz N, Fahey JL (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64(4):604–611

    Article  PubMed  Google Scholar 

  • Brambilla P, Bellani M, Isola M et al (2014) Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia. Transl Psychiatry 4:e406

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bruera E, Yennurajalingam S, Palmer JL et al (2013) Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol 31(19):2421–2427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD (2008) Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 63(11):1022–1029

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bufalino C, Hepgul N, Aguglia E, Pariante CM (2012) The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav Immun 31:31–47

    Article  PubMed  CAS  Google Scholar 

  • Butler JM Jr, Case LD, Atkins J et al (2007) A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 69(5):1496–1501

    Article  CAS  PubMed  Google Scholar 

  • Cagnin A, Kassiou M, Meikle SR, Banati RB (2007) Positron emission tomography imaging of neuroinflammation. Neurotherapeutics 4(3):443–452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Capuron L, Gumnick JF, Musselman DL et al (2002a) Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26(5):643–652

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ (2002b) Treatment of cytokine-induced depression. Brain Behav Immun 16(5):575–580

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Neurauter G, Musselman DL et al (2003) Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol Psychiatry 54(9):906–914

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Pagnoni G, Demetrashvili MF et al (2007) Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32(11):2384–2392

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Schroecksnadel S, Feart C et al (2011) Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 70:175–182

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Pagnoni G, Drake DF et al (2012) Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 69(10):1044–1053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cassano P, Lattanzi L, Soldani F et al (2004) Pramipexole in treatment-resistant depression: an extended follow-up. Depress Anxiety 20(3):131–138

    Article  CAS  PubMed  Google Scholar 

  • Cattaneo A, Gennarelli M, Uher R et al (2013) Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacology 38(3):377–385

    Article  CAS  PubMed  Google Scholar 

  • Cattaneo A, Ferrari C, Uher R et al (2016) Absolute measurements of macrophage migration inhibitory factor and interleukin-1-beta mRNA levels accurately predict treatment response in depressed patients. Int J Neuropsychopharmacol 19(10):pyw045

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Couzin-Frankel J (2010) Inflammation bares a dark side. Science 330(6011):1621

    Article  CAS  PubMed  Google Scholar 

  • Coventry BJ, Ashdown ML, Quinn MA, Markovic SN, Yatomi-Clarke SL, Robinson AP (2009) CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool? J Transl Med 7:102

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Creswell JD, Taren AA, Lindsay EK et al (2016) Alterations in resting-state functional connectivity link mindfulness meditation with reduced interleukin-6: a randomized controlled trial. Biol Psychiatry 80:53–61

    Article  CAS  PubMed  Google Scholar 

  • Cunnington C, Channon KM (2010) Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology. Heart 96(23):1872–1877

    Article  CAS  PubMed  Google Scholar 

  • Cusin C, Iovieno N, Iosifescu DV et al (2013) A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. J Clin Psychiatry 74(7):e636–e641

    Article  CAS  PubMed  Google Scholar 

  • Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B (2002) Motivation, reward, and Parkinson’s disease: influence of dopatherapy. Neuropsychologia 40(13):2257–2267

    Article  CAS  PubMed  Google Scholar 

  • Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A (2008) Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 65(4):409–415

    Article  PubMed  PubMed Central  Google Scholar 

  • Danese A, Caspi A, Williams B et al (2011) Biological embedding of stress through inflammation processes in childhood. Mol Psychiatry 16(3):244–246

    Article  CAS  PubMed  Google Scholar 

  • Dantzer R, Walker AK (2014) Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm 121:925–932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dantzer R, O’Connor JC, Lawson MA, Kelley KW (2011) Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36(3):426–436

    Article  CAS  PubMed  Google Scholar 

  • De La Garza RI, Asnis GM (2003) The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus. Brain Res 977(1):70–79

    Article  CAS  Google Scholar 

  • de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE (2010) Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299(2):G440–G448

    Article  CAS  Google Scholar 

  • del Rey A, Balschun D, Wetzel W, Randolf A, Besedovsky HO (2013) A cytokine network involving brain-borne IL-1beta, IL-1ra, IL-18, IL-6, and TNFalpha operates during long-term potentiation and learning. Brain Behav Immun 33:15–23

    Article  PubMed  CAS  Google Scholar 

  • Derecki NC, Cardani AN, Yang CH et al (2010) Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207(5):1067–1080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Devaraj S, Yun JM, Duncan-Staley C, Jialal I (2009) C-reactive protein induces M-CSF release and macrophage proliferation. J Leukoc Biol 85(2):262–267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Diekhof EK, Kaps L, Falkai P, Gruber O (2012) The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude – an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processing. Neuropsychologia 50(7):1252–1266

    Article  PubMed  Google Scholar 

  • D’Mello C, Le T, Swain MG (2009) Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29(7):2089–2102

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • D’Mello C, Ronaghan N, Zaheer R et al (2015) Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J Neurosci 35(30):10821–10830

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Donnelly S (1998) Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma. Oncol Nurs Forum 25(5):921–927

    CAS  PubMed  Google Scholar 

  • Dowell NG, Cooper EA, Tibble J et al (2016) Acute changes in striatal microstructure predict the development of interferon-alpha induced fatigue. Biol Psychiatry 79(4):320–328

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dowlati Y, Herrmann N, Swardfager W et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446–457

    Article  CAS  PubMed  Google Scholar 

  • Drago A, Crisafulli C, Calabro M, Serretti A (2015) Enrichment pathway analysis. The inflammatory genetic background in bipolar disorder. J Affect Disord 179:88–94

    Article  PubMed  CAS  Google Scholar 

  • Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64(3):327–337

    Article  CAS  PubMed  Google Scholar 

  • Dunn AJ, Swiergiel AH, de Beaurepaire R (2005) Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 29(4–5):891–909

    Article  CAS  PubMed  Google Scholar 

  • Eidelberg D, Moeller JR, Dhawan V et al (1994) The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14(5):783–801

    Article  CAS  PubMed  Google Scholar 

  • Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2009) An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. NeuroImage 47(3):881–890

    Article  CAS  PubMed  Google Scholar 

  • Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2010) Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 68(8):748–754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ericsson A, Kovacs KJ, Sawchenko PE (1994) A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14(2):897–913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Escalante CP, Meyers C, Reuben JM et al (2014) A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J 20(1):8–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Evans DL, Staab JP, Petitto JM et al (1999) Depression in the medical setting: biopsychological interactions and treatment considerations. J Clin Psychiatry 60(Suppl 4):40–55, discussion 56

    PubMed  Google Scholar 

  • Fabricatore AN, Wadden TA, Higginbotham AJ et al (2011) Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis. Int J Obes 35:1363–1376

    Article  CAS  Google Scholar 

  • Faridhosseini F, Sadeghi R, Farid L, Pourgholami M (2014) Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials. Hum Psychopharmacol 29(3):216–223

    Article  CAS  PubMed  Google Scholar 

  • Felger JC, Miller AH (2012) Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol 33(3):315–327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Felger JC, Treadway MT (2017) Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology 42(1):216–241

    Article  CAS  PubMed  Google Scholar 

  • Felger JC, Mun J, Kimmel HL et al (2013a) Chronic interferon-alpha decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology 38(11):2179–2187

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Felger JC, Li L, Marvar PJ et al (2013b) Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain Behav Immun 31:153–160

    Article  CAS  PubMed  Google Scholar 

  • Felger JC, Hernandez CR, Miller AH (2015) Levodopa reverses cytokine-induced reductions in striatal dopamine release. Int J Neuropsychopharmacol 18(4):pyu084

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Felger JC, Li Z, Haroon E et al (2016) Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 21(10):1358–1365

    Article  CAS  PubMed  Google Scholar 

  • Felger JC, Haroon E, Patel TA et al (2018) What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry

    Google Scholar 

  • Fleshner M (2011) The gut microbiota: a new player in the innate immune stress response? Brain Behav Immun 25(3):395–396

    Article  PubMed  Google Scholar 

  • Fleshner M (2013) Stress-evoked sterile inflammation, danger associated molecular patterns (DAMPs), microbial associated molecular patterns (MAMPs) and the inflammasome. Brain Behav Immun 27(1):1–7

    Article  CAS  PubMed  Google Scholar 

  • Forsythe LK, Wallace JM, Livingstone MB (2008) Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21(2):117–133

    Article  CAS  PubMed  Google Scholar 

  • Franco-Chaves JA, Mateus CF, Luckenbaugh DA, Martinez PE, Mallinger AG, Zarate CA Jr (2013) Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study. J Affect Disord 149(1–3):319–325

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Francois M, Romieu-Mourez R, Li M, Galipeau J (2012) Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20(1):187–195

    Article  CAS  PubMed  Google Scholar 

  • Frenois F, Moreau M, O’Connor J et al (2007) Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32(5):516–531

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Garver DL, Tamas RL, Holcomb JA (2003) Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacology 28(8):1515–1520

    Article  CAS  PubMed  Google Scholar 

  • Gimeno D, Kivimaki M, Brunner EJ et al (2009) Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 39(3):413–423

    Article  CAS  PubMed  Google Scholar 

  • Goldsmith DR, Haroon E, Woolwine BJ et al (2016) Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain Behav Immun 56:281–288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gong S, Sheng P, Jin H et al (2014) Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS One 9(1):e84391

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimaki M (2015) Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206–215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haber SN, Knutson B (2010) The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35(1):4–26

    Article  PubMed  Google Scholar 

  • Hannestad J, Gallezot JD, Schafbauer T et al (2012a) Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates. NeuroImage 63(1):232–239

    Article  CAS  PubMed  Google Scholar 

  • Hannestad J, Subramanyam K, Dellagioia N et al (2012b) Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans. J Nucl Med 53(4):601–607

    Article  CAS  PubMed  Google Scholar 

  • Hardingham GE, Fukunaga Y, Bading H (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5(5):405–414

    Article  CAS  PubMed  Google Scholar 

  • Haroon E, Woolwine BJ, Chen X et al (2014) IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacology 39(7):1777–1785

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haroon E, Felger JC, Woolwine BJ et al (2015) Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: preliminary findings. Brain Behav Immun 46:17–22

    Article  CAS  PubMed  Google Scholar 

  • Haroon E, Fleischer CC, Felger JC et al (2016) Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol Psychiatry 21(10):1351–1357

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haroon E, Miller AH, Sanacora G (2017) Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology 42(1):193–215

    Article  CAS  PubMed  Google Scholar 

  • Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD (2009a) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66(5):407–414

    Article  PubMed  PubMed Central  Google Scholar 

  • Harrison NA, Brydon L, Walker C et al (2009b) Neural origins of human sickness in interoceptive responses to inflammation. Biol Psychiatry 66(5):415–422

    Article  PubMed  PubMed Central  Google Scholar 

  • Harrison NA, Voon V, Cercignani M, Cooper EA, Pessiglione M, Critchley HD (2015a) A Neurocomputational account of how inflammation enhances sensitivity to punishments versus rewards. Biol Psychiatry 80:73–81

    Article  PubMed  Google Scholar 

  • Harrison NA, Cercignani M, Voon V, Critchley HD (2015b) Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants. Neuropsychopharmacology 40(4):831–838

    Article  PubMed  Google Scholar 

  • Hasler G, Fromm S, Carlson PJ et al (2008) Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 65(5):521–531

    Article  PubMed  PubMed Central  Google Scholar 

  • Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86(3):1009–1031

    Article  CAS  PubMed  Google Scholar 

  • Hodes GE, Pfau ML, Leboeuf M et al (2014) Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci U S A 111(45):16136–16141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171–186

    Article  CAS  PubMed  Google Scholar 

  • Ida T, Hara M, Nakamura Y, Kozaki S, Tsunoda S, Ihara H (2008) Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide. Neurosci Lett 432(3):232–236

    Article  CAS  PubMed  Google Scholar 

  • Imaizumi M, Kim HJ, Zoghbi SS et al (2007) PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett 411(3):200–205

    Article  CAS  PubMed  Google Scholar 

  • Inagaki TK, Muscatell KA, Irwin MR, Cole SW, Eisenberger NI (2012) Inflammation selectively enhances amygdala activity to socially threatening images. NeuroImage 59(4):3222–3226

    Article  PubMed  Google Scholar 

  • Iravani MM, Sadeghian M, Leung CC et al (2008) Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. Exp Neurol 212(2):522–531

    Article  CAS  PubMed  Google Scholar 

  • Irwin MR, Olmstead R, Breen EC et al (2015) Cognitive behavioral therapy and tai chi reverse cellular and genomic markers of inflammation in late-life insomnia: a randomized controlled trial. Biol Psychiatry 78(10):721–729

    Article  PubMed  PubMed Central  Google Scholar 

  • Iwata M, Ota KT, Duman RS (2013) The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 31:105–114

    Article  CAS  PubMed  Google Scholar 

  • Jamal O, Aneni EC, Shaharyar S et al (2014) Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome. Diabetol Metab Syndr 6:79–86

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Jha MK, Minhajuddin A, Gadad BS et al (2017) Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial. Psychoneuroendocrinology 78:105–113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Juengling FD, Ebert D, Gut O et al (2000) Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology 152(4):383–389

    Article  CAS  PubMed  Google Scholar 

  • Kamata M, Higuchi H, Yoshimoto M, Yoshida K, Shimizu T (2000) Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain. Eur Neuropsychopharmacol 10(2):129–132

    Article  CAS  PubMed  Google Scholar 

  • Katsuura G, Arimura A, Koves K, Gottschall PE (1990) Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. Am J Phys 258(1 Pt 1):E163–E171

    CAS  Google Scholar 

  • Khaodhiar L, Ling PR, Blackburn GL, Bistrian BR (2004) Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr 28(6):410–415

    Article  CAS  PubMed  Google Scholar 

  • Kiecolt-Glaser JK, Bennett JM, Andridge R et al (2014) Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol 32(10):1040–1049

    Article  PubMed  PubMed Central  Google Scholar 

  • Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M (2004) T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci U S A 101(21):8180–8185

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kiraly DD, Horn SR, Van Dam NT et al (2017) Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl Psychiatry 7(3):e1065

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kitagami T, Yamada K, Miura H, Hashimoto R, Nabeshima T, Ohta T (2003) Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier. Brain Res 978(1–2):104–114

    Article  CAS  PubMed  Google Scholar 

  • Kohler O, Benros ME, Nordentoft M et al (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiat 71(12):1381–1391

    Article  Google Scholar 

  • Kumai T, Tateishi T, Tanaka M, Watanabe M, Shimizu H, Kobayashi S (2000) Effect of interferon-alpha on tyrosine hydroxylase and catecholamine levels in the brain of rats. Life Sci 67(6):663–669

    Article  CAS  PubMed  Google Scholar 

  • Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V (1999) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40(4):171–176

    Article  CAS  PubMed  Google Scholar 

  • Lewitus GM, Cohen H, Schwartz M (2008) Reducing post-traumatic anxiety by immunization. Brain Behav Immun 22(7):1108–1114

    Article  CAS  PubMed  Google Scholar 

  • Lieb J, Karmali R, Horrobin D (1983) Elevated levels of prostaglandin E2 and thromboxane B2 in depression. Prostaglandins Leukot Med 10(4):361–367

    Article  CAS  PubMed  Google Scholar 

  • Lim W, Hong S, Nelesen R, Dimsdale JE (2005) The association of obesity, cytokine levels, and depressive symptoms with diverse measures of fatigue in healthy subjects. Arch Intern Med 165(8):910–915

    Article  PubMed  Google Scholar 

  • Lindqvist D, Janelidze S, Hagell P et al (2009) Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 66(3):287–292

    Article  CAS  PubMed  Google Scholar 

  • Loftis JM, Hauser P, Macey TA, Lowe JD (2006a) Can rodents be used to model interferon-alpha-induced depressive symptoms? Prog Neuro-Psychopharmacol Biol Psychiatry 30(7):1364–1365 author reply 1366

    Article  CAS  Google Scholar 

  • Loftis JM, Wall JM, Pagel RL, Hauser P (2006b) Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats. Psychoneuroendocrinology 31(10):1289–1294

    Article  CAS  PubMed  Google Scholar 

  • Maes M (1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25–46

    Article  CAS  PubMed  Google Scholar 

  • Maes M, Lambrechts J, Bosmans E et al (1992) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22(1):45–53

    Article  CAS  PubMed  Google Scholar 

  • Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9(11):853–858

    Article  CAS  PubMed  Google Scholar 

  • Majer M, Welberg LA, Capuron L, Pagnoni G, Raison CL, Miller AH (2008) IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun 22(6):870–880

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mar Fan HG, Clemons M, Xu W et al (2008) A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16(6):577–583

    Article  PubMed  Google Scholar 

  • Martinez JM, Garakani A, Yehuda R, Gorman JM (2012) Proinflammatory and “resiliency” proteins in the CSF of patients with major depression. Depress Anxiety 29(1):32–38

    Article  CAS  PubMed  Google Scholar 

  • Maslanik T, Mahaffey L, Tannura K, Beninson L, Greenwood BN, Fleshner M (2012) The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure. Brain Behav Immun 28:54–62

    Article  PubMed  CAS  Google Scholar 

  • Meier-Ewert HK, Ridker PM, Rifai N et al (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43(4):678–683

    Article  CAS  PubMed  Google Scholar 

  • Mentis MJ, McIntosh AR, Perrine K et al (2002) Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson’s disease. Am J Psychiatry 159(5):746–754

    Article  PubMed  Google Scholar 

  • Miller GE, Cole SW (2012) Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol Psychiatry 72(1):34–40

    Article  PubMed  PubMed Central  Google Scholar 

  • Miller AH, Raison CL (2015) Are anti-inflammatory therapies viable treatments for psychiatric disorders? Where the rubber meets the road. JAMA Psychiat 72(6):527–528

    Article  Google Scholar 

  • Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26(6):971–982

    Article  CAS  PubMed  Google Scholar 

  • Miller AH, Haroon E, Felger JC (2017) Therapeutic implications of brain-immune interactions: treatment in translation. Neuropsychopharmacology 42(1):334–359

    Article  CAS  PubMed  Google Scholar 

  • Mocking RJ, Harmsen I, Assies J, Koeter MW, Ruhe HG, Schene AH (2016) Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry 6:e756

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moraska AR, Sood A, Dakhil SR et al (2010) Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol 28(23):3673–3679

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moron JA, Zakharova I, Ferrer JV et al (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23(24):8480–8488

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morrow GR, Hickok JT, Roscoe JA et al (2003) Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21(24):4635–4641

    Article  CAS  PubMed  Google Scholar 

  • Mostafavi S, Battle A, Zhu X et al (2014) Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry 19(12):1267–1274

    Article  CAS  PubMed  Google Scholar 

  • Motivala SJ, Sarfatti A, Olmos L, Irwin MR (2005) Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67(2):187–194

    Article  CAS  PubMed  Google Scholar 

  • Muscatell KA, Dedovic K, Slavich GM et al (2015) Greater amygdala activity and dorsomedial prefrontal-amygdala coupling are associated with enhanced inflammatory responses to stress. Brain Behav Immun 43:46–53

    Article  PubMed  Google Scholar 

  • Musselman DL, Lawson DH, Gumnick JF et al (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344(13):961–966

    Article  CAS  PubMed  Google Scholar 

  • Na KS, Lee KJ, Lee JS, Cho YS, Jung HY (2014) Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry 48:79–85

    Article  CAS  Google Scholar 

  • Naude PJ, Dobos N, van der Meer D et al (2014) Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice. Behav Brain Res 258:43–51

    Article  CAS  PubMed  Google Scholar 

  • Neurauter G, Schrocksnadel K, Scholl-Burgi S et al (2008) Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab 9(7):622–627

    Article  CAS  PubMed  Google Scholar 

  • Nierenberg AA (2015) Residual symptoms in depression: prevalence and impact. J Clin Psychiatry 76(11):e1480

    Article  PubMed  Google Scholar 

  • Nunes EJ, Randall PA, Estrada A et al (2014) Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/chow feeding choice task. Psychopharmacology 231(4):727–736

    Article  CAS  PubMed  Google Scholar 

  • O’Connor JC, Lawson MA, Andre C et al (2009a) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511–522

    Article  PubMed  CAS  Google Scholar 

  • O’Connor JC, Lawson MA, Andre C et al (2009b) Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 182(5):3202–3212

    Article  PubMed  CAS  Google Scholar 

  • O’Connor MF, Irwin MR, Wellisch DK (2009c) When grief heats up: pro-inflammatory cytokines predict regional brain activation. NeuroImage 47(3):891–896

    Article  PubMed  CAS  Google Scholar 

  • Opp MR, Born J, Irwin MR (2007) Sleep and the immune system. In: Ader R (ed) Psychoneuroimmunology. Academic Press, New York, pp 570–618

    Google Scholar 

  • Pace TW, Mletzko TC, Alagbe O et al (2006) Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 163(9):1630–1633

    Article  PubMed  Google Scholar 

  • Pan W, Kastin AJ (2003) Interactions of cytokines with the blood-brain barrier: implications for feeding. Curr Pharm Des 9(10):827–831

    Article  CAS  PubMed  Google Scholar 

  • Papakostas GI, Petersen T, Mischoulon D et al (2004) Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 65(8):1090–1095

    Article  CAS  PubMed  Google Scholar 

  • Papakostas GI, Shelton RC, Zajecka JM et al (2012) L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 169(12):1267–1274

    Article  PubMed  Google Scholar 

  • Park HS, Park JY, Yu R (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69(1):29–35

    Article  CAS  PubMed  Google Scholar 

  • Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442(7106):1042–1045

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pollak Y, Yirmiya R (2002) Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5(4):389–399

    Article  CAS  PubMed  Google Scholar 

  • Price RB, Nock MK, Charney DS, Mathew SJ (2009) Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66(5):522–526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pucci E, Branas P, D’Amico R, Giuliani G, Solari A, Taus C (2007) Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 1:CD002818

    Google Scholar 

  • Raison CL, Miller AH (2003) Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54(3):283–294

    Article  PubMed  Google Scholar 

  • Raison CL, Miller AH (2013) The evolutionary significance of depression in pathogen host defense (PATHOS-D). Mol Psychiatry 18(1):15–37

    Article  CAS  PubMed  Google Scholar 

  • Raison CL, Demetrashvili M, Capuron L, Miller AH (2005a) Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 19(2):105–123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raison CL, Borisov AS, Broadwell SD et al (2005b) Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 66(1):41–48

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raison CL, Borisov AS, Majer M et al (2009) Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 65(4):296–303

    Article  CAS  PubMed  Google Scholar 

  • Raison CL, Rye DB, Woolwine BJ et al (2010a) Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry 68(10):942–949

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raison CL, Dantzer R, Kelley KW et al (2010b) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15(4):393–403

    Article  CAS  PubMed  Google Scholar 

  • Raison CL, Rutherford RE, Woolwine BJ et al (2013a) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat 70(1):31–41

    Article  CAS  Google Scholar 

  • Raison CL, Felger JC, Miller AH (2013b) Inflammation and treatment resistance in major depression: a perfect storm. Psychiatric Times, 12 Sept

    Google Scholar 

  • Ramanan D, Bowcutt R, Lee SC et al (2016) Helminth infection promotes colonization resistance via type 2 immunity. Science 352(6285):608–612

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Randall PA, Lee CA, Podurgiel SJ et al (2015) Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol 18(2):pyu017

    Article  PubMed Central  CAS  Google Scholar 

  • Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A (2012) Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr 107(Suppl 2):S159–S170

    Article  CAS  PubMed  Google Scholar 

  • Rapaport MH, Nierenberg AA, Schettler PJ et al (2016) Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol Psychiatry 21(1):71–79

    Article  CAS  PubMed  Google Scholar 

  • Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C (2005) Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8(2):147–148

    Article  CAS  PubMed  Google Scholar 

  • Rhodes B, Furnrohr BG, Vyse TJ (2011) C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol 7(5):282–289

    Article  CAS  PubMed  Google Scholar 

  • Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363–369

    Article  PubMed  Google Scholar 

  • Rosenblat JD, Kakar R, Berk M et al (2016) Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord 18(2):89–101

    Article  CAS  PubMed  Google Scholar 

  • Ruddy KJ, Barton D, Loprinzi CL (2014) Laying to rest psychostimulants for cancer-related fatigue? J Clin Oncol 32(18):1865–1867

    Article  CAS  PubMed  Google Scholar 

  • Rush AJ (2007) STAR*D: what have we learned? Am J Psychiatry 164(2):201–204

    Article  PubMed  Google Scholar 

  • Russo SJ, Nestler EJ (2013) The brain reward circuitry in mood disorders. Nat Rev Neurosci 14(9):609–625

    Article  CAS  PubMed  Google Scholar 

  • Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O’Connor JC (2012) Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav 62(3):202–209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Samanez-Larkin GR, Knutson B (2015) Decision making in the ageing brain: changes in affective and motivational circuits. Nat Rev Neurosci 16(5):278–289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sandiego CM, Gallezot JD, Pittman B et al (2015) Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A 112(40):12468–12473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Santamaria A, Flores-Escartin A, Martinez JC et al (2003) Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems. Free Radic Biol Med 35(4):418–427

    Article  CAS  PubMed  Google Scholar 

  • Sarris J, Price LH, Carpenter LL et al (2015) Is S-adenosyl methionine (SAMe) for depression only effective in males? A re-analysis of data from a randomized clinical trial. Pharmacopsychiatry 48(4–5):141–144

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sato T, Suzuki E, Yokoyama M, Semba J, Watanabe S, Miyaoka H (2006) Chronic intraperitoneal injection of interferon-alpha reduces serotonin levels in various regions of rat brain, but does not change levels of serotonin transporter mRNA, nitrite or nitrate. Psychiatry Clin Neurosci 60(4):499–506

    Article  CAS  PubMed  Google Scholar 

  • Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B (2016) Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J Psychiatr Res 77:42–51

    Article  PubMed  Google Scholar 

  • Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303(1):1–10

    Article  CAS  PubMed  Google Scholar 

  • Schwartz M, Shechter R (2010) Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease. Mol Psychiatry 15(4):342–354

    Article  CAS  PubMed  Google Scholar 

  • Schwieler L, Larsson MK, Skogh E et al (2015) Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia – significance for activation of the kynurenine pathway. J Psychiatry Neurosci 40(2):126–133

    Article  PubMed  PubMed Central  Google Scholar 

  • Setiawan E, Wilson AA, Mizrahi R et al (2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiat 72:268–275

    Article  Google Scholar 

  • Shelton RC, Miller AH (2010) Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 91(4):275–299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M et al (2011) Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16(7):751–762

    Article  CAS  PubMed  Google Scholar 

  • Shelton RC, Pencina MJ, Barrentine LW et al (2015) Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs. J Clin Psychiatry 76(12):1635–1641

    Article  PubMed  Google Scholar 

  • Shi M, Liu ZW, Wang FS (2011) Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 164(1):1–8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R (1997) Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747(2):348–351

    Article  CAS  PubMed  Google Scholar 

  • Sluzewska A (1999) Indicators of immune activation in depressed patients. Adv Exp Med Biol 461:59–73

    Article  CAS  PubMed  Google Scholar 

  • Soderlund J, Schroder J, Nordin C et al (2009) Activation of brain interleukin-1beta in schizophrenia. Mol Psychiatry 14(12):1069–1071

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Soderlund J, Olsson SK, Samuelsson M et al (2011) Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder. J Psychiatry Neurosci 36(2):114–118

    Article  PubMed  PubMed Central  Google Scholar 

  • Song C, Merali Z, Anisman H (1999) Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2, or interleukin-6 treatment. Neuroscience 88(3):823–836

    Article  CAS  PubMed  Google Scholar 

  • Spetsieris PG, Moeller JR, Dhawan V, Ishikawa T, Eidelberg D (1995) Visualizing the evolution of abnormal metabolic networks in the brain using PET. Comput Med Imaging Graph 19(3):295–306

    Article  CAS  PubMed  Google Scholar 

  • Stankoff B, Waubant E, Confavreux C et al (2005) Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 64(7):1139–1143

    Article  CAS  PubMed  Google Scholar 

  • Steiner J, Walter M, Gos T et al (2011) Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 8:94

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440(7087):1054–1059

    Article  CAS  PubMed  Google Scholar 

  • Stone TW (2000) Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends Pharmacol Sci 21(4):149–154

    Article  CAS  PubMed  Google Scholar 

  • Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ (2015) Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol 25(10):1532–1543

    Article  CAS  PubMed  Google Scholar 

  • Suarez EC (2008) Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 22(6):960–968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Suganami T, Ogawa Y (2010) Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 88(1):33–39

    Article  CAS  PubMed  Google Scholar 

  • Sugawara Y, Akechi T, Shima Y et al (2002) Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med 16(3):261–263

    Article  PubMed  Google Scholar 

  • Takaki J, Fujimori K, Miura M, Suzuki T, Sekino Y, Sato K (2012) L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammation. J Neuroinflammation 9:275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Targum SD, Fava M (2011) Fatigue as a residual symptom of depression. Innov Clin Neurosci 8(10):40–43

    PubMed  PubMed Central  Google Scholar 

  • Tavares RG, Tasca CI, Santos CES et al (2002) Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40(7):621–627

    Article  CAS  PubMed  Google Scholar 

  • Tavares RG, Schmidt AP, Abud J, Tasca CI, Souza DO (2005) In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine. Neurochem Res 30(4):439–444

    Article  CAS  PubMed  Google Scholar 

  • Tilleux S, Hermans E (2007) Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85(10):2059–2070

    Article  CAS  PubMed  Google Scholar 

  • Torres-Platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N (2014) Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 42:50–59

    Article  CAS  PubMed  Google Scholar 

  • Trivedi MH, Hollander E, Nutt D, Blier P (2008) Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry 69(2):246–258

    Article  PubMed  Google Scholar 

  • Uher R, Tansey KE, Dew T et al (2014) An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry 171:1278–1286

    Article  PubMed  Google Scholar 

  • Venneti S, Lopresti BJ, Wang G et al (2007) A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. J Neurochem 102(6):2118–2131

    Article  CAS  PubMed  Google Scholar 

  • Vgontzas AN, Zoumakis E, Bixler EO et al (2004) Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89(5):2119–2126

    Article  CAS  PubMed  Google Scholar 

  • Walker AK, Budac DP, Bisulco S et al (2013) NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology 38(9):1609–1616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang J, Campbell IL, Zhang H (2008) Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system. Mol Psychiatry 13(3):293–301

    Article  CAS  PubMed  Google Scholar 

  • Watkins LR, Wiertelak EP, Goehler LE et al (1994) Neurocircuitry of illness-induced hyperalgesia. Brain Res 639(2):283–299

    Article  CAS  PubMed  Google Scholar 

  • Watkins LR, Goehler LE, Relton JK et al (1995) Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 183(1–2):27–31

    Article  CAS  PubMed  Google Scholar 

  • Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796–1808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wichmann T, DeLong MR (1999) Oscillations in the basal ganglia. Nature 400(6745):621–622

    Article  CAS  PubMed  Google Scholar 

  • Wichmann T, DeLong MR (2003) Functional neuroanatomy of the basal ganglia in Parkinson’s disease. Adv Neurol 91:9–18

    PubMed  Google Scholar 

  • Wilson AA, Garcia A, Parkes J et al (2008) Radiosynthesis and initial evaluation of [18 F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol 35(3):305–314

    Article  CAS  PubMed  Google Scholar 

  • Wium-Andersen MK, Orsted DD, Nielsen SF, Nordestgaard BG (2013) Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiat 70(2):176–184

    Article  CAS  Google Scholar 

  • Wohleb ES, Fenn AM, Pacenta AM, Powell ND, Sheridan JF, Godbout JP (2012) Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology 37(9):1491–1505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wohleb ES, McKim DB, Shea DT et al (2014) Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry 75(12):970–981

    Article  CAS  PubMed  Google Scholar 

  • Wolf SA, Steiner B, Akpinarli A et al (2009) CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J Immunol 182(7):3979–3984

    Article  CAS  PubMed  Google Scholar 

  • Wong ML, Inserra A, Lewis MD et al (2016) Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry 21:797–805

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Woods JA, Vieira VJ, Keylock KT (2009) Exercise, inflammation, and innate immunity. Immunol Allergy Clin N Am 29(2):381–393

    Article  Google Scholar 

  • Wu HQ, Rassoulpour A, Schwarcz R (2007) Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm 114(1):33–41

    Article  PubMed  Google Scholar 

  • Yang JJ, Wang N, Yang C, Shi JY, Yu HY, Hashimoto K (2015) Serum interleukin-6 is a predictive biomarker for ketamine’s antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry 77(3):e19–e20

    Article  CAS  PubMed  Google Scholar 

  • Yirmiya R, Goshen I (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25(2):181–213

    Article  CAS  PubMed  Google Scholar 

  • Yirmiya R, Weidenfeld J, Pollak Y et al (1999) Cytokines, “depression due to a general medical condition,” and antidepressant drugs. Adv Exp Med Biol 461:283–316

    Article  CAS  PubMed  Google Scholar 

  • Yirmiya R, Pollak Y, Morag M et al (2000) Illness, cytokines, and depression. Ann N Y Acad Sci 917:478–487

    Article  CAS  PubMed  Google Scholar 

  • Yohn SE, Thompson C, Randall PA et al (2015) The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology 232(7):1313–1323

    Article  CAS  PubMed  Google Scholar 

  • Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005) p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280(16):15649–15658

    Article  CAS  PubMed  Google Scholar 

  • Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31(10):2121–2131

    Article  CAS  PubMed  Google Scholar 

  • Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA (2010) Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35:2510–2520

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ziv Y, Ron N, Butovsky O et al (2006) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9(2):268–275

    Article  CAS  PubMed  Google Scholar 

  • Zoller H, Schloegl A, Schroecksnadel S, Vogel W, Fuchs D (2012) Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio. J Interf Cytokine Res 32(5):216–220

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Emory University School of Medicine, Atlanta, GA, USA

    Jennifer C. Felger

Authors
  1. Jennifer C. Felger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer C. Felger .

Editor information

Editors and Affiliations

  1. School of Medicine-Wichita, University of Kansas, Wichita, KS, USA

    Matthew Macaluso

  2. School of Medicine-Wichita, University of Kansas, Wichita, KS, USA

    Sheldon H. Preskorn

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Felger, J.C. (2018). Role of Inflammation in Depression and Treatment Implications. In: Macaluso, M., Preskorn, S. (eds) Antidepressants. Handbook of Experimental Pharmacology, vol 250. Springer, Cham. https://doi.org/10.1007/164_2018_166

Download citation

Publish with us

Policies and ethics

Search

Navigation